The application of regenerative medicine for the treatment of PFCD using adipose-derived stem cells (ADSCs) is emerging as a safe and innovative treatment option. In this interactive research summary, the practical clinical use of ADSCs are discussed, including autologous and allogeneic cell sources, appropriate patient candidates, and injection techniques, along with a review of current clinical data for ADSCs in PFCD.
- Provider:Paradigm Medical Communications, LLC
- Activity Link: https://ce.paradigmmc.com/a/EVZECU
- Start Date: 2024-02-29 06:00:00
- End Date: 2024-02-29 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
- Commercial Support: Source: Takeda Pharmaceuticals (Any division) - Amount: 73700.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest